| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | decreased prepulse inhibition | 8.99e-05 | 464 | 15 | 5 | MP:0009142 | |
| MousePheno | increased cranium width | 1.82e-04 | 19 | 15 | 2 | MP:0000441 | |
| MousePheno | abnormal prepulse inhibition | 1.87e-04 | 542 | 15 | 5 | MP:0003088 | |
| Domain | Fam133 | 1.09e-06 | 2 | 20 | 2 | IPR026766 | |
| Domain | EPHD | 2.48e-04 | 22 | 20 | 2 | PS51805 | |
| Domain | ZnF_C2HC | 1.56e-03 | 55 | 20 | 2 | SM00343 | |
| Domain | Znf_CCHC | 1.56e-03 | 55 | 20 | 2 | IPR001878 | |
| Domain | Zinc_finger_PHD-type_CS | 2.18e-03 | 65 | 20 | 2 | IPR019786 | |
| Domain | PHD | 2.88e-03 | 75 | 20 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 3.19e-03 | 79 | 20 | 2 | IPR019787 | |
| Domain | PHD | 4.03e-03 | 89 | 20 | 2 | SM00249 | |
| Domain | Znf_PHD | 4.21e-03 | 91 | 20 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.58e-03 | 95 | 20 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 4.68e-03 | 96 | 20 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.07e-02 | 147 | 20 | 2 | IPR011011 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.61e-02 | 1022 | 8 | 3 | MM15436 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.19e-07 | 701 | 21 | 7 | 30196744 | |
| Pubmed | 3.48e-07 | 251 | 21 | 5 | 31076518 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.17e-06 | 807 | 21 | 6 | 22681889 | |
| Pubmed | 6.61e-06 | 206 | 21 | 4 | 34185411 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 8.05e-06 | 1318 | 21 | 7 | 30463901 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 8.83e-06 | 486 | 21 | 5 | 30940648 | |
| Pubmed | 1.04e-05 | 1371 | 21 | 7 | 36244648 | ||
| Pubmed | 1.10e-05 | 72 | 21 | 3 | 12777385 | ||
| Pubmed | 1.36e-05 | 1429 | 21 | 7 | 35140242 | ||
| Pubmed | 1.45e-05 | 1442 | 21 | 7 | 35575683 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.60e-05 | 954 | 21 | 6 | 36373674 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.89e-05 | 269 | 21 | 4 | 29511261 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 2.30e-05 | 283 | 21 | 4 | 28533407 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 2.51e-05 | 604 | 21 | 5 | 37616343 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 7.44e-05 | 759 | 21 | 5 | 35915203 | |
| Pubmed | 1.50e-04 | 30 | 21 | 2 | 11483580 | ||
| Pubmed | 1.82e-04 | 483 | 21 | 4 | 36912080 | ||
| Pubmed | 1.96e-04 | 1497 | 21 | 6 | 31527615 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 2.12e-04 | 949 | 21 | 5 | 36574265 | |
| Pubmed | 2.59e-04 | 208 | 21 | 3 | 11790298 | ||
| Pubmed | 2.66e-04 | 210 | 21 | 3 | 16565220 | ||
| Pubmed | 3.24e-04 | 44 | 21 | 2 | 27505670 | ||
| Pubmed | 3.26e-04 | 225 | 21 | 3 | 12168954 | ||
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 3.69e-04 | 47 | 21 | 2 | 29934401 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.88e-04 | 1082 | 21 | 5 | 38697112 | |
| Pubmed | 4.18e-04 | 245 | 21 | 3 | 19521500 | ||
| Pubmed | 4.47e-04 | 1116 | 21 | 5 | 31753913 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 5.24e-04 | 56 | 21 | 2 | 26919559 | |
| Pubmed | 5.78e-04 | 655 | 21 | 4 | 35819319 | ||
| Interaction | DDX23 interactions | 3.62e-07 | 480 | 21 | 7 | int:DDX23 | |
| Interaction | SDCBP2 interactions | 8.56e-07 | 72 | 21 | 4 | int:SDCBP2 | |
| Interaction | NOP56 interactions | 1.15e-06 | 570 | 21 | 7 | int:NOP56 | |
| Interaction | JMJD6 interactions | 1.85e-06 | 205 | 21 | 5 | int:JMJD6 | |
| Interaction | GNL2 interactions | 2.02e-06 | 386 | 21 | 6 | int:GNL2 | |
| Interaction | CSNK2A1 interactions | 2.92e-06 | 956 | 21 | 8 | int:CSNK2A1 | |
| Interaction | MYCN interactions | 4.28e-06 | 1373 | 21 | 9 | int:MYCN | |
| Interaction | NOS1AP interactions | 5.21e-06 | 113 | 21 | 4 | int:NOS1AP | |
| Interaction | CSNK2A2 interactions | 5.32e-06 | 718 | 21 | 7 | int:CSNK2A2 | |
| Interaction | NKAP interactions | 9.65e-06 | 132 | 21 | 4 | int:NKAP | |
| Interaction | PNN interactions | 1.22e-05 | 302 | 21 | 5 | int:PNN | |
| Interaction | C1orf35 interactions | 1.26e-05 | 304 | 21 | 5 | int:C1orf35 | |
| Interaction | NKAPD1 interactions | 2.11e-05 | 161 | 21 | 4 | int:NKAPD1 | |
| Interaction | ZC3H14 interactions | 2.56e-05 | 169 | 21 | 4 | int:ZC3H14 | |
| Interaction | CSNK2B interactions | 3.17e-05 | 625 | 21 | 6 | int:CSNK2B | |
| Interaction | SNRNP40 interactions | 3.52e-05 | 637 | 21 | 6 | int:SNRNP40 | |
| Interaction | FBL interactions | 3.58e-05 | 639 | 21 | 6 | int:FBL | |
| Interaction | CBX3 interactions | 3.81e-05 | 646 | 21 | 6 | int:CBX3 | |
| Interaction | HECTD1 interactions | 4.12e-05 | 984 | 21 | 7 | int:HECTD1 | |
| Interaction | NIPBL interactions | 4.84e-05 | 199 | 21 | 4 | int:NIPBL | |
| Interaction | MACROH2A2 interactions | 6.08e-05 | 211 | 21 | 4 | int:MACROH2A2 | |
| Interaction | ST18 interactions | 6.78e-05 | 12 | 21 | 2 | int:ST18 | |
| Interaction | CDK8 interactions | 7.40e-05 | 222 | 21 | 4 | int:CDK8 | |
| Interaction | ZNF330 interactions | 7.88e-05 | 446 | 21 | 5 | int:ZNF330 | |
| Interaction | FAM133A interactions | 7.90e-05 | 81 | 21 | 3 | int:FAM133A | |
| Interaction | FOLR1 interactions | 8.07e-05 | 227 | 21 | 4 | int:FOLR1 | |
| Interaction | KLF6 interactions | 1.27e-04 | 95 | 21 | 3 | int:KLF6 | |
| Interaction | PES1 interactions | 1.32e-04 | 258 | 21 | 4 | int:PES1 | |
| Interaction | RP9 interactions | 1.43e-04 | 99 | 21 | 3 | int:RP9 | |
| Interaction | LHX1 interactions | 1.61e-04 | 103 | 21 | 3 | int:LHX1 | |
| Interaction | EN1 interactions | 1.96e-04 | 110 | 21 | 3 | int:EN1 | |
| Interaction | PRPF3 interactions | 2.10e-04 | 291 | 21 | 4 | int:PRPF3 | |
| Interaction | COIL interactions | 2.14e-04 | 552 | 21 | 5 | int:COIL | |
| Interaction | ELK3 interactions | 2.53e-04 | 120 | 21 | 3 | int:ELK3 | |
| Interaction | MLLT1 interactions | 2.72e-04 | 123 | 21 | 3 | int:MLLT1 | |
| Interaction | H2AJ interactions | 2.99e-04 | 127 | 21 | 3 | int:H2AJ | |
| Interaction | USP36 interactions | 3.13e-04 | 599 | 21 | 5 | int:USP36 | |
| Interaction | EIF3J interactions | 3.20e-04 | 130 | 21 | 3 | int:EIF3J | |
| Interaction | CT45A1 interactions | 3.31e-04 | 26 | 21 | 2 | int:CT45A1 | |
| Interaction | NUP43 interactions | 3.80e-04 | 625 | 21 | 5 | int:NUP43 | |
| Interaction | NR2C2 interactions | 3.81e-04 | 1403 | 21 | 7 | int:NR2C2 | |
| Interaction | ATF7IP interactions | 3.82e-04 | 138 | 21 | 3 | int:ATF7IP | |
| Interaction | MIDN interactions | 3.83e-04 | 626 | 21 | 5 | int:MIDN | |
| Interaction | FOXQ1 interactions | 4.07e-04 | 141 | 21 | 3 | int:FOXQ1 | |
| Interaction | SOX15 interactions | 4.07e-04 | 141 | 21 | 3 | int:SOX15 | |
| Interaction | FTL interactions | 4.15e-04 | 348 | 21 | 4 | int:FTL | |
| Interaction | BRD7 interactions | 4.15e-04 | 637 | 21 | 5 | int:BRD7 | |
| Interaction | DPF2 interactions | 4.19e-04 | 349 | 21 | 4 | int:DPF2 | |
| Interaction | SMC5 interactions | 4.19e-04 | 1000 | 21 | 6 | int:SMC5 | |
| Interaction | FAM133B interactions | 4.72e-04 | 31 | 21 | 2 | int:FAM133B | |
| Interaction | PAX6 interactions | 5.01e-04 | 366 | 21 | 4 | int:PAX6 | |
| Interaction | RPL31 interactions | 5.59e-04 | 680 | 21 | 5 | int:RPL31 | |
| Interaction | CENPA interactions | 5.61e-04 | 377 | 21 | 4 | int:CENPA | |
| Interaction | UTP4 interactions | 7.01e-04 | 170 | 21 | 3 | int:UTP4 | |
| Interaction | SRPK2 interactions | 7.12e-04 | 717 | 21 | 5 | int:SRPK2 | |
| Interaction | LHX2 interactions | 8.68e-04 | 183 | 21 | 3 | int:LHX2 | |
| Interaction | CDK11B interactions | 8.68e-04 | 183 | 21 | 3 | int:CDK11B | |
| Interaction | NHERF2 interactions | 8.68e-04 | 183 | 21 | 3 | int:NHERF2 | |
| Interaction | RNPS1 interactions | 8.78e-04 | 425 | 21 | 4 | int:RNPS1 | |
| Interaction | STAC3 interactions | 9.10e-04 | 43 | 21 | 2 | int:STAC3 | |
| Interaction | GATA3 interactions | 9.24e-04 | 187 | 21 | 3 | int:GATA3 | |
| Interaction | ATG16L1 interactions | 9.26e-04 | 1161 | 21 | 6 | int:ATG16L1 | |
| Interaction | CEP44 interactions | 9.53e-04 | 189 | 21 | 3 | int:CEP44 | |
| Interaction | MTA2 interactions | 9.57e-04 | 435 | 21 | 4 | int:MTA2 | |
| Interaction | ADSL interactions | 1.03e-03 | 194 | 21 | 3 | int:ADSL | |
| Interaction | KLF12 interactions | 1.03e-03 | 194 | 21 | 3 | int:KLF12 | |
| Interaction | KLF5 interactions | 1.04e-03 | 195 | 21 | 3 | int:KLF5 | |
| Interaction | PRPF40A interactions | 1.05e-03 | 446 | 21 | 4 | int:PRPF40A | |
| Interaction | ZBTB2 interactions | 1.09e-03 | 450 | 21 | 4 | int:ZBTB2 | |
| Interaction | IRF9 interactions | 1.09e-03 | 47 | 21 | 2 | int:IRF9 | |
| Interaction | PWP1 interactions | 1.09e-03 | 198 | 21 | 3 | int:PWP1 | |
| Interaction | ARID4B interactions | 1.11e-03 | 199 | 21 | 3 | int:ARID4B | |
| Interaction | YY1 interactions | 1.12e-03 | 454 | 21 | 4 | int:YY1 | |
| Interaction | JADE2 interactions | 1.13e-03 | 48 | 21 | 2 | int:JADE2 | |
| Interaction | RAD18 interactions | 1.15e-03 | 457 | 21 | 4 | int:RAD18 | |
| Interaction | UTP20 interactions | 1.26e-03 | 208 | 21 | 3 | int:UTP20 | |
| Interaction | PNISR interactions | 1.28e-03 | 51 | 21 | 2 | int:PNISR | |
| Interaction | TSPYL5 interactions | 1.28e-03 | 51 | 21 | 2 | int:TSPYL5 | |
| Interaction | SRPK1 interactions | 1.35e-03 | 477 | 21 | 4 | int:SRPK1 | |
| Interaction | PAF1 interactions | 1.36e-03 | 214 | 21 | 3 | int:PAF1 | |
| Interaction | C1orf226 interactions | 1.38e-03 | 53 | 21 | 2 | int:C1orf226 | |
| Interaction | IK interactions | 1.38e-03 | 215 | 21 | 3 | int:IK | |
| Interaction | IFI6 interactions | 1.43e-03 | 54 | 21 | 2 | int:IFI6 | |
| Interaction | NAA35 interactions | 1.43e-03 | 54 | 21 | 2 | int:NAA35 | |
| Interaction | C7orf50 interactions | 1.44e-03 | 218 | 21 | 3 | int:C7orf50 | |
| Interaction | CMTR1 interactions | 1.44e-03 | 218 | 21 | 3 | int:CMTR1 | |
| Interaction | JPH3 interactions | 1.49e-03 | 55 | 21 | 2 | int:JPH3 | |
| Interaction | ERCC6 interactions | 1.55e-03 | 224 | 21 | 3 | int:ERCC6 | |
| Interaction | MECP2 interactions | 1.58e-03 | 1287 | 21 | 6 | int:MECP2 | |
| Interaction | AP1M1 interactions | 1.59e-03 | 226 | 21 | 3 | int:AP1M1 | |
| Interaction | CDK7 interactions | 1.61e-03 | 501 | 21 | 4 | int:CDK7 | |
| Interaction | RPS6 interactions | 1.73e-03 | 874 | 21 | 5 | int:RPS6 | |
| Interaction | GTF2F1 interactions | 1.76e-03 | 234 | 21 | 3 | int:GTF2F1 | |
| Interaction | ZCCHC10 interactions | 1.80e-03 | 236 | 21 | 3 | int:ZCCHC10 | |
| Interaction | U2AF1 interactions | 1.87e-03 | 239 | 21 | 3 | int:U2AF1 | |
| Interaction | IFI27L1 interactions | 2.07e-03 | 65 | 21 | 2 | int:IFI27L1 | |
| Interaction | KPNA3 interactions | 2.08e-03 | 248 | 21 | 3 | int:KPNA3 | |
| Interaction | DHX40 interactions | 2.10e-03 | 249 | 21 | 3 | int:DHX40 | |
| Interaction | ASF1A interactions | 2.10e-03 | 249 | 21 | 3 | int:ASF1A | |
| Interaction | SREK1IP1 interactions | 2.13e-03 | 66 | 21 | 2 | int:SREK1IP1 | |
| GeneFamily | PHD finger proteins | 1.31e-03 | 90 | 11 | 2 | 88 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 1.71e-05 | 198 | 21 | 4 | M5018 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_DN | 1.74e-05 | 199 | 21 | 4 | M4852 | |
| Coexpression | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN | 9.28e-05 | 18 | 21 | 2 | M16533 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 2.10e-04 | 1144 | 21 | 6 | MM3843 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 2.81e-04 | 761 | 21 | 5 | M11961 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 2.92e-04 | 1215 | 21 | 6 | M41122 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_8HR | 4.45e-04 | 39 | 21 | 2 | M1641 | |
| Coexpression | GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP | 4.60e-04 | 191 | 21 | 3 | M3298 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.83e-04 | 856 | 21 | 5 | M4500 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.11e-04 | 198 | 21 | 3 | M9119 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN | 5.11e-04 | 198 | 21 | 3 | M8768 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_8HR | 5.16e-04 | 42 | 21 | 2 | MM691 | |
| Coexpression | GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP | 5.18e-04 | 199 | 21 | 3 | M5064 | |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_UP | 5.18e-04 | 199 | 21 | 3 | M4865 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 5.26e-04 | 200 | 21 | 3 | M8635 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP | 5.26e-04 | 200 | 21 | 3 | M8638 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_24H_BMDC_DN | 5.26e-04 | 200 | 21 | 3 | M3954 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP | 5.26e-04 | 200 | 21 | 3 | M8305 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M8330 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN | 5.26e-04 | 200 | 21 | 3 | M8297 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKCELL_UP | 5.26e-04 | 200 | 21 | 3 | M4783 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 6.20e-04 | 904 | 21 | 5 | M2325 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.11e-07 | 532 | 21 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.77e-05 | 162 | 21 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.36e-05 | 204 | 21 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.81e-05 | 469 | 21 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.29e-04 | 1241 | 21 | 7 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.42e-04 | 277 | 21 | 4 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.50e-04 | 281 | 21 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.57e-04 | 284 | 21 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.22e-04 | 311 | 21 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.40e-04 | 596 | 21 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | 2.89e-04 | 983 | 21 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 2.99e-04 | 989 | 21 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | 3.02e-04 | 991 | 21 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 3.65e-04 | 1468 | 21 | 7 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.71e-04 | 655 | 21 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 4.19e-04 | 150 | 21 | 3 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 4.35e-04 | 152 | 21 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.63e-04 | 166 | 21 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 6.09e-04 | 406 | 21 | 4 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 6.49e-04 | 413 | 21 | 4 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 6.56e-04 | 175 | 21 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_100 | 7.83e-04 | 42 | 21 | 2 | Facebase_ST1_e10.5_MaxilArch_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 1.05e-03 | 1252 | 21 | 6 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 1.07e-03 | 1257 | 21 | 6 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.11e-03 | 210 | 21 | 3 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#2_top-relative-expression-ranked_500 | 1.15e-03 | 51 | 21 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.17e-03 | 484 | 21 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 1.28e-03 | 496 | 21 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500 | 1.39e-03 | 56 | 21 | 2 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.44e-03 | 230 | 21 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.69e-03 | 243 | 21 | 3 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.81e-03 | 249 | 21 | 3 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.03e-03 | 259 | 21 | 3 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.06e-03 | 564 | 21 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.19e-03 | 266 | 21 | 3 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 2.30e-03 | 983 | 21 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 2.30e-03 | 1459 | 21 | 6 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 2.37e-03 | 989 | 21 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.40e-03 | 275 | 21 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.56e-05 | 177 | 21 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | C_00|World / shred on cell type and cluster | 7.81e-05 | 179 | 21 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | 3'_v3-blood|World / Manually curated celltypes from each tissue | 8.89e-05 | 187 | 21 | 3 | 9e70e8d7cd8ae517ddf5fd56c69ec16fc33ddff5 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 188 | 21 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 9.62e-05 | 192 | 21 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.04e-04 | 197 | 21 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 197 | 21 | 3 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-04 | 197 | 21 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-04 | 199 | 21 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-04 | 200 | 21 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.08e-04 | 200 | 21 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Disease | fasting blood glucose measurement | 9.18e-04 | 287 | 20 | 3 | EFO_0004465 | |
| Disease | squamous cell carcinoma | 9.40e-04 | 67 | 20 | 2 | EFO_0000707 | |
| Disease | Disproportionate short stature | 1.24e-03 | 77 | 20 | 2 | C0878659 | |
| Disease | lipid measurement, lipoprotein measurement | 1.69e-03 | 90 | 20 | 2 | EFO_0004529, EFO_0004732 | |
| Disease | sunburn | 1.92e-03 | 96 | 20 | 2 | EFO_0003958 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.04e-03 | 99 | 20 | 2 | EFO_0004639, EFO_0008595 | |
| Disease | suntan | 2.20e-03 | 103 | 20 | 2 | EFO_0004279 | |
| Disease | eosinophil measurement | 2.42e-03 | 108 | 20 | 2 | EFO_0803540 | |
| Disease | remnant cholesterol measurement | 2.42e-03 | 108 | 20 | 2 | EFO_0010815 | |
| Disease | free cholesterol measurement | 2.64e-03 | 113 | 20 | 2 | EFO_0008591 | |
| Disease | R-6-hydroxywarfarin measurement | 2.69e-03 | 114 | 20 | 2 | EFO_0803327 | |
| Disease | keratinocyte carcinoma | 2.87e-03 | 118 | 20 | 2 | EFO_0010176 | |
| Disease | polyunsaturated fatty acid measurement | 3.53e-03 | 131 | 20 | 2 | EFO_0010733 | |
| Disease | skin pigmentation measurement | 3.85e-03 | 137 | 20 | 2 | EFO_0007009 | |
| Disease | cataract | 4.07e-03 | 141 | 20 | 2 | MONDO_0005129 | |
| Disease | Disease Exacerbation | 5.53e-03 | 165 | 20 | 2 | C0235874 | |
| Disease | sexual dimorphism measurement | 5.88e-03 | 1106 | 20 | 4 | EFO_0021796 | |
| Disease | age at menarche | 7.17e-03 | 594 | 20 | 3 | EFO_0004703 | |
| Disease | HMG CoA reductase inhibitor use measurement | 7.19e-03 | 189 | 20 | 2 | EFO_0009932 | |
| Disease | basal cell carcinoma | 7.19e-03 | 189 | 20 | 2 | EFO_0004193 | |
| Disease | colorectal cancer | 7.51e-03 | 604 | 20 | 3 | MONDO_0005575 | |
| Disease | neuropsychological test | 7.79e-03 | 197 | 20 | 2 | EFO_0003926 | |
| Disease | hair colour measurement | 7.89e-03 | 615 | 20 | 3 | EFO_0007822 | |
| Disease | urate measurement, bone density | 8.03e-03 | 619 | 20 | 3 | EFO_0003923, EFO_0004531 | |
| Disease | body surface area | 8.91e-03 | 643 | 20 | 3 | EFO_0022196 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.21e-03 | 215 | 20 | 2 | EFO_0008317, EFO_0008591 | |
| Disease | DNA methylation | 9.41e-03 | 656 | 20 | 3 | GO_0006306 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.96e-03 | 224 | 20 | 2 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.00e-02 | 225 | 20 | 2 | EFO_0008317, EFO_0010351 | |
| Disease | chronic kidney disease | 1.09e-02 | 235 | 20 | 2 | EFO_0003884 | |
| Disease | Major Depressive Disorder | 1.16e-02 | 243 | 20 | 2 | C1269683 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKSSSHSLSHKGKKL | 301 | P55198 | |
| KAKSKHKEKSDKEHS | 1251 | Q6UB99 | |
| KGKKKESCSKHASGT | 96 | Q9ULD4 | |
| HKPSKTKTSKSSKVK | 616 | Q9ULK2 | |
| VGKSSSKKKKKFHKA | 576 | O00567 | |
| KKHSKKKKKKSGSSH | 231 | Q8N9E0 | |
| EKGKKHKKRSSSKNT | 631 | Q6NUN7 | |
| ASKKKDKGHSSSKKS | 256 | Q70Z53 | |
| KTKGDSSHSEKKTAK | 26 | O95613 | |
| HSKKKKKKAASSSPD | 231 | Q5BKY9 | |
| SSSSSSKKKKTKVEH | 31 | P29084 | |
| SSSSEGKEKHKKKKK | 176 | Q8TA86 | |
| KSSTHESRKHKKSKK | 141 | Q6ZUT1 | |
| KKKKKGKKSSSAEGH | 241 | Q13610 | |
| TKTDKSSSGAKKKDF | 496 | Q9UHF7 | |
| ARHTSKDSKAAKKKK | 216 | Q9NP64 | |
| KSEKETTSKKNSHKK | 86 | Q8IY57 | |
| SKKIFSKTKTHGSKD | 1251 | Q6AHZ1 | |
| NKKKSHKSSEGSGKK | 466 | Q9NQ66 | |
| KKSTTKDSKKHSGSD | 741 | Q8TF01 | |
| KTKHKDGSSEKHKDK | 66 | P11387 |